Figure 1 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action حسب James P.B. O’Connor (15037863)

"…<b>A,</b> Increased retention of the fluorescent cytotoxic metabolite of banoxantrone, AQ4, as oxygen concentration decreased, with (<b>B</b>) example images shown for cells exposed to 10 µmol/L of banoxantrone differing oxygenation conditions. …"

Analysis of variance results (mean sum of squares and significance) for the effect of soil types, crop species, and diuron doses on plant and their interactions on crop growth resp... حسب Win Win Pyone (20396432)

No significant differences in the numbers of eggs between Mst1^+/+ and Mst1^ΔM/ΔM mice. حسب Jianyang Li (461703)

Landmark detailed analysis of the cranium and mandibular phenotypes in Dp(16)1Yey. حسب José Tomás Ahumada Saavedra (22290934)

"…(B) Form difference matrix analysis: FDM Bootstrap with 10,000 iterations showing significant changes in Form (p = 0.008). The FDM confidence interval graph shows a decrease of more than 90% of the distances measured. …"

Data Sheet 1_Eupalinolide A inhibits cancer progression and induces ferroptosis and apoptosis by targeting the AMPK/mTOR/SCD1 signalling in non-small cell lung cancer.docx حسب Yonghui Zhang (279832)

"…EA treatment (25 mg/kg) markedly inhibited tumour growth in vivo in a xenograft model; both tumour weight and tumour volume decreased by more than 60% without significantly affecting the body weight of tumour-bearing mice.…"

Differential miRNA target gene pathway enrichment bubble map. حسب Zhaowen Tan (12283502)

الموضوعات:

qRT-PCR results of differentially expressed miRNAs in rats’ myocardial tissue after training. حسب Zhaowen Tan (12283502)

الموضوعات:

Volcano plot and clustering of differentially expressed miRNAs. حسب Zhaowen Tan (12283502)

الموضوعات:

Summary of miRNAs sequencing data quality. حسب Zhaowen Tan (12283502)

الموضوعات:

Differential expression of miRNAs in SHR-SED group and BFRT group (all miRNAs). حسب Zhaowen Tan (12283502)

الموضوعات:

Histogram of the GO functional enrichment of differential miRNA target genes. حسب Zhaowen Tan (12283502)

الموضوعات:

The miRNA target genes. حسب Zhaowen Tan (12283502)

الموضوعات:

Changes in SHR body weight, hemodynamics and cardiac function before and after training. حسب Zhaowen Tan (12283502)

الموضوعات:

Table of miRNA comparisons with reference genomes. حسب Zhaowen Tan (12283502)

الموضوعات:

Figure 2 from mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of <i>PIK3CA</i>-Altered Tumors حسب Constance A. Sobsey (19373550)

"…Node size increases as the <i>P</i>-value decreases. <b>B,</b> Top 20 canonical pathways that are significantly differentially activated between clinical benefit (CB) and no clinical benefit (NCB) groups, based on assessment with Fisher’s exact test in Qiagen IPA. …"

Statistical association (P < 0.10) between background factors and dog owners’ attitude (AT), subjective norms (SN) and perceived behavioral control (PBC) that were significantly as... حسب Fentahun Mengie (20862454)

الموضوعات:

Shape rescue in the midface phenotype in the Dp(16)1Yey/ <i>Ripply3</i>^<i>tm1b</i> compound mutant. حسب José Tomás Ahumada Saavedra (22290934)

"…In light blue, the structures with no significant changes. On the left, the histogram of every point distance evaluated (in this case, more than 1.238.684 points) and the surface differences with the color code for the increase-decrease dimensions (Red to green).…"

Image 4_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... حسب Yun Xu (139234)

"…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). However, with the increasing number of phase 3 randomized controlled trials (RCTs) published in recent years, it is essential to re-evaluate the validity of this conclusion and to comprehensively assess the efficacy and safety across diverse patient subgroups.…"

Image 5_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... حسب Yun Xu (139234)

"…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). However, with the increasing number of phase 3 randomized controlled trials (RCTs) published in recent years, it is essential to re-evaluate the validity of this conclusion and to comprehensively assess the efficacy and safety across diverse patient subgroups.…"

Table 4_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... حسب Yun Xu (139234)

"…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). However, with the increasing number of phase 3 randomized controlled trials (RCTs) published in recent years, it is essential to re-evaluate the validity of this conclusion and to comprehensively assess the efficacy and safety across diverse patient subgroups.…"